Main description:

This third volume in the successful 'Drug Discovery in Infectious Diseases' series is the first to deal with drug discovery in helminthic infections in human and animals. The result is a broad overview of different drug target evaluation methods, including specific examples of successful drug development against helminthes, and with a whole section devoted to vaccine development. With its well-balanced mix of high-profile contributors from academia and industry, this handbook and reference will appeal to a wide audience, including parasitologists, pharmaceutical industry, epidemiologists, and veterinary scientists.

Contents:

Foreword to Parasitic Helminths: Targets, Screens, Drugs and Vaccines V Preface XI List of Contributors XIII Part One Targets 1 1 Ligand-Gated Ion Channels as Targets for Anthelmintic Drugs: Past, Current, and Future Perspectives 3 Kristin Lees, Ann Sluder, Niroda Shannan, Lance Hammerland, and David Sattelle 2 How Relevant is Caenorhabditis elegans as a Model for the Analysis of Parasitic Nematode Biology? 23 Lindy Holden-Dye and Robert J. Walker 3 Integrating and Mining Helminth Genomes to Discover and Prioritize Novel Therapeutic Targets 43 Dhanasekaran Shanmugam, Stuart A. Ralph, Santiago J. Carmona, Gregory J. Crowther, David S. Roos, and Fernan Aguero 4 Recent Progress in Transcriptomics of Key Gastrointestinal Nematodes of Animals Fundamental Research Toward New Intervention Strategies 61 Cinzia Cantacessi, Bronwyn E. Campbell, Aaron R. Jex, Ross S. Hall, Neil D. Young, Matthew J. Nolan, and Robin B. Gasser 5 Harnessing Genomic Technologies to Explore the Molecular Biology of Liver Flukes-Major Implications for Fundamental and Applied Research 73 Neil D. Young, Aaron R. Jex, Cinzia Cantacessi, Bronwyn E. Campbell, and Robin B. Gasser 6 RNA Interference: A Potential Discovery Tool for Therapeutic Targets of Parasitic Nematodes 89 Collette Britton 7 RNA Interference as a Tool for Drug Discovery in Parasitic Flatworms 105 Akram A. Da.dara and Patrick J. Skelly Part Two Screens 121 8 Mechanism-Based Screening Strategies for Anthelmintic Discovery 123 Timothy G. Geary 9 Identification and Profiling of Nematicidal Compounds in Veterinary Parasitology 135 Andreas Rohwer, Jurgen Lutz, Christophe Chassaing, Manfred Uphoff, Anja R. Heckeroth, and Paul M. Selzer 10 Quantitative High-Content Screening-Based Drug Discovery against Helmintic Diseases 159 Rahul Singh 11 Use of Rodent Models in the Discovery of Novel Anthelmintics 181 Rebecca Fankhauser, Linsey R. Cozzie, Bakela Nare, Kerrie Powell, Ann E. Sluder, and Lance G. Hammerland 12 To Kill a Mocking Worm: Strategies to Improve Caenorhabditis elegans as a Model System for use in Anthelmintic Discovery 201 Andrew R. Burns and Peter J. Roy Part Three Drugs 217 13 Anthelmintic Drugs: Tools and Shortcuts for the Long Road from Discovery to Product 219 Eugenio L. de Hostos and Tue Nguyen 14 Antinematodal Drugs Modes of Action and Resistance: And Worms Will Not Come to Thee (Shakespeare: Cymbeline: IV, ii) 233 Alan P. Robertson, Samuel K. Buxton, Sreekanth Puttachary, Sally M. Williamson, Adrian J. Wolstenholme, Cedric Neveu, Jacques Cabaret, Claude L. Charvet, and Richard J. Martin 15 Drugs and Targets to Perturb the Symbiosis of Wolbachia and Filarial Nematodes 251 Mark J. Taylor, Louise Ford, Achim Hoerauf, Ken Pfarr, Jeremy M. Foster, Sanjay Kumar, and Barton E. Slatko 16 Promise of Bacillus thuringiensis Crystal Proteins as Anthelmintics 267 Yan Hu and Raffi V. Aroian 17 Monepantel: From Discovery to Mode of Action 283 Ronald Kaminsky and Lucien Rufener 18 Discovery, Mode of Action, and Commercialization of Derquantel 297 Debra J. Woods, Steven J. Maeder, Alan P. Robertson, Richard J. Martin, Timothy G. Geary, David P. Thompson, Sandra S. Johnson, and George A. Conder 19 Praziquantel: Too Good to be Replaced? 309 Livia Pica-Mattoccia and Donato Cioli 20 Drug Discovery for Trematodiases: Challenges and Progress 323 Conor R. Caffrey, Jurg Utzinger, and Jennifer Keiser Part Four Vaccines 341 21 Barefoot thru. the Valley of Darkness: Preclinical Development of a Human Hookworm Vaccine 343 Jeffrey M. Bethony, Maria Victoria Periago, and Amar R. Jariwala 22 Vaccines Linked to Chemotherapy: A New Approach to Control Helminth Infections 357 Sara Lustigman, James H. McKerrow, and Maria Elena Bottazzi 23 Antifilarial Vaccine Development: Present and Future Approaches 377 Sara Lustigman, David Abraham, and Thomas R. Klei 24 Proteases as Vaccines Against Gastrointestinal Nematode Parasites of Sheep and Cattle 399 David Knox 25 Schistosomiasis Vaccines New Approaches to Antigen Discovery and Promising New Candidates 421 Alex Loukas, Soraya Gaze, Mark Pearson, Denise Doolan, Philip Felgner, David Diemert, Donald P. McManus, Patrick Driguez, and Jeffrey Bethony 26 Sm14 Schistosoma mansoni Fatty Acid-Binding Protein: Molecular Basis for an Antihelminth Vaccine 435 Miriam Tendler, Celso Raul Romero Ramos, and Andrew J.G. Simpson 27 Mechanisms of Immune Modulation by Fasciola hepatica: Importance for Vaccine Development and for Novel Immunotherapeutics 451 Mark W. Robinson, John P. Dalton, Sandra M. O.Neill, and Sheila M. Donnelly 28 Prospects for Immunoprophylaxis Against Fasciola hepatica (Liver Fluke) 465 Terry W. Spithill, Carlos Carmona, David Piedrafita, and Peter M. Smooker 29 Vaccines Against Cestode Parasites 485 Marshall W. Lightowlers, Charles G. Gauci, Abdul Jabbar, and Cristian Alvarez Index 505